Core Scientific Inc

CORZ remains in a Stage 4 decline under down-sloping 9EMA, 20EMA, and 50 DMA, with price trading below key moving averages and displaying sequential lower highs and lower lows. Extreme oversold readings have prompted a short-term bounce off the 200 DMA, but lack of sustained reversal suggests downward momentum remains intact. Active Support Failure pattern confirms supply dominance, so bearish asymmetry holds. We will defer selling and seek to trim into rallies toward the 9EMA/20EMA/50DMA resistance zone, looking for rejections as confirmation of renewed selling pressure.

• ↑Pivot to high-density HPC with $6.7B potential revenue
• ↑Secured 382 MW CoreWeave contract to boost gross margins
• ↓Over 50% of contracted capacity with CoreWeave, concentration risk